Haemonetics HAE Income Statement
| FY'26 | FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|---|
| $1.33B-2.0% | $1.36B+4.0% | $1.31B+12.0% | $1.17B+17.7% | ||
| $546.44M-10.7% | $611.87M-0.9% | $617.51M+11.6% | $553.56M+13.5% | ||
| $787.59M+5.2% | $748.96M+8.3% | $691.55M+12.4% | $615.1M+21.7% | ||
| 59%+4.0pp | 55%+2.2pp | 52.8%+0.2pp | 52.6%+1.7pp | ||
| $59.77M-4.7% | $62.72M+15.2% | $54.44M+8.6% | $50.13M+7.1% | ||
| $442.42M+1.3% | $436.79M+1.6% | $429.78M+14.1% | $376.68M+10.7% | ||
| $630.85M+19.7% | $527.14M+0.1% | $526.67M+14.7% | $459.06M+8.1% | ||
| —— | $221.82M+34.5% | $164.88M+5.7% | $156.03M+93.2% | ||
| -$28.7M-195% | -$9.75M+25.1% | -$13.02M+11.0% | -$14.63M+14.5% | ||
| —— | $212.07M+39.6% | $151.87M+7.4% | $141.4M+122% | ||
| —— | $44.39M+29.4% | $34.31M+31.9% | $26M+28.4% | ||
| —— | $167.68M+42.6% | $117.56M+1.9% | $115.4M+166% | ||
| —— | $3.31+44.5% | $2.29+2.7% | $2.23+165% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Haemonetics's profit margins?
- Gross margin is 59.0% and operating margin is 19.0%, with a 13.3% net margin.
- Where does Haemonetics's income statement data come from?
- Every line is extracted from Haemonetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.